223 related articles for article (PubMed ID: 30863989)
61. Development of a microphysiological model of human kidney proximal tubule function.
Weber EJ; Chapron A; Chapron BD; Voellinger JL; Lidberg KA; Yeung CK; Wang Z; Yamaura Y; Hailey DW; Neumann T; Shen DD; Thummel KE; Muczynski KA; Himmelfarb J; Kelly EJ
Kidney Int; 2016 Sep; 90(3):627-37. PubMed ID: 27521113
[TBL] [Abstract][Full Text] [Related]
62. Characteristics of cadmium-induced nephrotoxicity in Syrian hamsters.
Shibasaki T; Ohno I; Ishimoto F; Sakai O
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):913-7. PubMed ID: 8255000
[TBL] [Abstract][Full Text] [Related]
63. Functional Evaluation and Nephrotoxicity Assessment of Human Renal Proximal Tubule Cells on a Chip.
Jing B; Yan L; Li J; Luo P; Ai X; Tu P
Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140103
[TBL] [Abstract][Full Text] [Related]
64. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
65. Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells.
Cai H; Agrawal AK; Putt DA; Hashim M; Reddy A; Brodfuehrer J; Surendran N; Lash LH
Toxicology; 2009 Apr; 258(1):56-63. PubMed ID: 19378467
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells.
Huang JX; Kaeslin G; Ranall MV; Blaskovich MA; Becker B; Butler MS; Little MH; Lash LH; Cooper MA
Pharmacol Res Perspect; 2015 Jun; 3(3):e00148. PubMed ID: 26171227
[TBL] [Abstract][Full Text] [Related]
67. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
68. Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.
Gunness P; Aleksa K; Kosuge K; Ito S; Koren G
Can J Physiol Pharmacol; 2010 Apr; 88(4):448-55. PubMed ID: 20555413
[TBL] [Abstract][Full Text] [Related]
69. Renal proximal tubular cells in suspension or in primary culture as in vitro models to study nephrotoxicity.
Boogaard PJ; Nagelkerke JF; Mulder GJ
Chem Biol Interact; 1990; 76(3):251-91. PubMed ID: 2225232
[TBL] [Abstract][Full Text] [Related]
70. Cultured human proximal tubule cells as a model for aminoglycoside nephrotoxicity.
Sens MA; Hennigar GR; Hazen-Martin DJ; Blackburn JG; Sens DA
Ann Clin Lab Sci; 1988; 18(3):204-14. PubMed ID: 3389717
[TBL] [Abstract][Full Text] [Related]
71. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments.
Astashkina A; Grainger DW
Adv Drug Deliv Rev; 2014 Apr; 69-70():1-18. PubMed ID: 24613390
[TBL] [Abstract][Full Text] [Related]
72. Effective reconstruction of functional organotypic kidney spheroid for in vitro nephrotoxicity studies.
Kang HM; Lim JH; Noh KH; Park D; Cho HS; Susztak K; Jung CR
Sci Rep; 2019 Nov; 9(1):17610. PubMed ID: 31772214
[TBL] [Abstract][Full Text] [Related]
73. Drug toxicity in the proximal tubule: new models, methods and mechanisms.
Hall AM; Trepiccione F; Unwin RJ
Pediatr Nephrol; 2022 May; 37(5):973-982. PubMed ID: 34050397
[TBL] [Abstract][Full Text] [Related]
74. Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content.
Zager RA
Am J Kidney Dis; 2000 Aug; 36(2):238-49. PubMed ID: 10922301
[TBL] [Abstract][Full Text] [Related]
75. Dichlorovinyl cysteine (DCVC) in the mouse kidney: tissue-binding and toxicity after glutathione depletion and probenecid treatment.
Darnerud PO; Brandt I; Feil VJ; Bakke JE
Arch Toxicol; 1989; 63(5):345-50. PubMed ID: 2818197
[TBL] [Abstract][Full Text] [Related]
76. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
[TBL] [Abstract][Full Text] [Related]
77. Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death.
Zager RA; Johnson AC; Naito M; Bomsztyk K
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F187-97. PubMed ID: 17942567
[TBL] [Abstract][Full Text] [Related]
78. A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity.
Qu Y; An F; Luo Y; Lu Y; Liu T; Zhao W; Lin B
Biomaterials; 2018 Feb; 155():41-53. PubMed ID: 29169037
[TBL] [Abstract][Full Text] [Related]
79. Self-eating for death or survival during cisplatin nephrotoxicity?
Jiang M; Dong Z
Clin Exp Nephrol; 2010 Oct; 14(5):516-7. PubMed ID: 20700622
[No Abstract] [Full Text] [Related]
80. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.
Hoffmann D; Fuchs TC; Henzler T; Matheis KA; Herget T; Dekant W; Hewitt P; Mally A
Toxicology; 2010 Nov; 277(1-3):49-58. PubMed ID: 20816719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
